definiens: means ( i ) [ * * * * * ] produc t comprised of Lipid Nanoparticles ( LNP ) containing [ * * * * * ] mRNA Constructs intended [ * * * * * ] where the Target is selected from the Targets available to [COMPANY] on the Reserved Target List and where such product is derived from, is based on, or utilizes any Acuitas LNP Technology ; and/or ( ii ) [ * * * * * ] Licensed Vaccine Product . If a given protein, e.g., an antibody comprises separated amino acid -chains, or a given Vaccine comprises multiple antigens or antibodies, which may be delivered as separated mRNA Const ructs ( combined in one LNP or delivered in separated LNPs ), such product would be considered as one Licensed Product . For the avoidance of doubt, the term Licensed Product in respect of a given Target encompasses all variants of such Target, including the wild types, naturally occurring variants, engineered variants wherein modifications to the native amino acid sequence have been made ( for example, mutated versions, derivatives or fragments ) and species homologs and orthologs thereof, provided, however, th at any such naturally occurring variant, engineered variant or species homolog or ortholog possesses substantially similar biological activity to such Target(s ) ( for example antigenicity in case of antigens )